Our data suggest that EphA7 might have a tumor suppressive role in mesothelioma, since EphA7 depletion did not prevent progranulin-dependent AKT and MAPK activation but led instead to an increase in basal activation of these two signaling pathways. The gene discussed is AKT1; the disease is neoplasm.